首页> 外文期刊>Annals of surgical oncology >Concomitant Seminal Vesicle Invasion in pT4a Urothelial Carcinoma of the Bladder with Contiguous Prostatic Infiltration is an Adverse Prognosticator for Cancer-Specific Survival after Radical Cystectomy
【24h】

Concomitant Seminal Vesicle Invasion in pT4a Urothelial Carcinoma of the Bladder with Contiguous Prostatic Infiltration is an Adverse Prognosticator for Cancer-Specific Survival after Radical Cystectomy

机译:膀胱pT4a尿路上皮癌伴有前列腺浸润的同时精囊侵犯是根治性膀胱切除术后特定于癌症生存的不良预后指标

获取原文
获取原文并翻译 | 示例
           

摘要

Results: A total of 229 patients (59.5 %) without cSVI comprised group A, and 156 patients (40.5 %) with cSVI comprised group B. Positive lymph nodes (63 vs. 44 %, p < 0.001) and positive surgical margins (34 % vs. 14 %, p < 0.001) were more common in patients with cSVI. The 5- and 10-year cancer-specific survival rates were 41 % and 32 % (group A) and 21 and 17 % (group B) (p < 0.001). In multivariable analysis, pathological nodal stage (hazard ratio [HR] 2.19, p < 0.001), soft tissue surgical margin (HR 1.57, p = 0.010), clinical tumor stage (HR 1.46, p = 0.010), adjuvant chemotherapy (HR 0.40, p < 0.001), and cSVI (HR 1.69, p < 0.001) independently impacted cancer-specific mortality. The c-indices of the multivariable models with and without inclusion of cSVI were 0.658 (95 % confidence interval 0.60 0.71) and 0.635 (95 % confidence interval 0.58 0.69), respectively, resulting in a predictive accuracy gain of 2.3 % (p = 0.002).Conclusions: In patients with UCB and prostatic stromal invasion, cSVI adversely affected cancer-specific survival compared to patients without cSVI. The inclusion of cSVI significantly improved the predictive accuracy of our multivariable model regarding survival.Purpose: To evaluate the prognostic value of concomitant seminal vesicle invasion (cSVI) in patients with urothelial carcinoma of the bladder (UCB) and contiguous prostatic stromal infiltration in a large cystectomy series.Methods: A total of 385 patients with UCB and contiguous prostatic infiltration comprised our study. Patients were divided in two groups according to cSVI. Median follow-up was 36 months (interquartile range 11 74); the primary end point was cancer-specific mortality. The prognostic impact of cSVI was evaluated using multivariable Cox regression analysis. The predictive accuracy was assessed by a receiver operating characteristic analysis.
机译:结果:A组共有229例无cSVI的患者(59.5%),B组则有156例cSVI的患者(40.5%)。淋巴结阳性(63%vs. 44%,p <0.001)和手术切缘阳性(34) %vs. 14%,p <0.001)在cSVI患者中更为常见。 5年和10年癌症特异性生存率分别为41%和32%(A组)以及21和17%(B组)(p <0.001)。在多变量分析中,病理性淋巴结分期(危险比[HR] 2.19,p <0.001),软组织手术切缘(HR 1.57,p = 0.010),临床肿瘤分期(HR 1.46,p = 0.010),辅助化疗(HR 0.40) (p <0.001)和cSVI(HR 1.69,p <0.001)独立影响癌症特异性死亡率。包含cSVI和不包含cSVI的多变量模型的c指数分别为0.658(95%置信区间0.60 0.71)和0.635(95%置信区间0.58 0.69),从而使预测精度提高了2.3%(p = 0.002)结论:与没有cSVI的患者相比,在患有UCB和前列腺间质浸润的患者中,cSVI对癌症特异性存活率产生不利影响。目的:评估围产期膀胱膀胱癌(UCB)和连续性前列腺间质浸润患者同时精囊浸润(cSVI)对预后的价值。方法:本研究共计385例UCB和连续性前列腺浸润患者。根据cSVI将患者分为两组。中位随访时间为36个月(四分位间距为11 74);主要终点是癌症特异性死亡率。使用多变量Cox回归分析评估cSVI的预后影响。通过接收器工作特性分析评估了预测准确性。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号